This program has a clinical focus.
Program Details
- Intended Audience: Pharmacists interested associated with the Advent Health Residency Program
- Universal Activity Number: 0012-0000-22-030-L99-P
- Contact Hours: 1.0 General hours of ACPE continuing education for pharmacists
- Program Fees: Complimentary for pharmacists associated with the Advent Health Residency Program
- Dates Available: 07/01/2022-06/30/2023
- Activity Type: Knowledge
- Program Support: No outside financial support was provided.
Objectives
At the completion of this activity, the participant will be able to:
- Discuss a novel, controversial, or cutting-edge therapeutic topic used by pharmacists at a tertiary care health system.
- Review and analyze current literature related to pharmacotherapy and disease state management.
- Describe pertinent pharmacology and pharmacokinetics of medications utilized in disease state management.
- Demonstrate narratively how the new pharmacotherapeutic information will be applied to pharmacy practice at a tertiary care health system.
Requirements for Successful Course Completion
Attendance at the RSS Grand Rounds presentation and submit an evaluation within 15 days of the presentation.
Schedule of Activities
| Title | Presenter | Date and Time |
|---|---|---|
| Outpatient Treatment Options for COVID-19 | Myla Nguyen | October 19, 2022 |
| Treatment options for GIB in LVAD patients | Jessica Behnam | October 25, 2022 |
| Toxicological Emergencies in Pediatrics | Rosie Nagy | November 3, 2022 |
| Management controversies of acute agitation in the ED | Patrick Funderburk | November 8. 2022 |
| Diabetic Kidney Disease | Amber Johnson | November 9, 2022 |
| Updates in HER2 Positive Breast Cancer Treatment | Alexis Ertle | November 10, 2022 |
| Novel Therapies in ALL | Ariana Terravecchia | November 15, 2022 |
| Controversies in TXA utilization | Yeji Lee | November 29. 2022 |
| Gold 2022 Guideline Updates | Sandy Louka | December 16, 2022 |
| GNR Bacteremia Controversies | Emma Ballantyne | December 20, 2022 |
| Submersion injuries | Taylor Vandenberg | December 22, 2022 |
| Use of Direct Oral Anticoagulants in Cirrhosis | Maha Fansa | January 3, 2023 |
| Burnout and early departure in clinical pharmacists | Gabriella Perez | January 10, 2023 |
| beta watch yo self: Beta-lactam induced neurotoxicity | Olivia Funk | January 12, 2023 |
| CC OB | Michelle Dillon | January 17, 2023 |
| TBD | Jose Lugo-Martinez | January 18, 2023 |
| Glycemic mgmt in the critically/acutely ill patients | Jennifer Wilson | January 24, 2023 |
| Sleep in the ICU | Emily Bennett | January 31, 2023 |
| Updates of HF Guidelines - Improving GDTM - Utilization of ARNI and SGLT2i | Keaton Kaplan | February 1, 2023 |
| Review of oncologic emergienes (FN, TLS, Hypercalcemia etc) | Rebecca Falter | February 2, 2023 |
| Phenobarbital for AWS | Lindsey Selph | February 7, 2023 |
| Clostridium difficile Infection - A Review of 2021 Guideline Updates from IDSA and ACG | Yalda Saba | February 8, 2023 |
| Atrial fibrillation in critically ill patients | Brittany Allison | February 9, 2023 |
| 2022 Heart Failure Guideline Update | Alexandra Cruz Pabon | February 14, 2023 |
| Ocular emergencies- intraocular pressure management/infection/exposures | Maitri Patel | February 21, 2023 |
| Antithrombotics in TAVR/TAVI | Alexandra Cunha | February 23, 2023 |
| Blood pressure managemnt in neuro ICU | Caitlyn Lawrence | February 28, 2023 |
| ACEI related Angioedema: What options do we have | Ashley Guzman Melero | March 1, 2023 |
| Review of non-malignant heme type topics (hemophilia, sickle cell, ITP/TTP/HUS, etc) | Cheng Ieng Wong | March 2, 2023 |
| Nerve blocks vs systemic medications in the ED- local anesthetics and role of Exparel? | Nicholas Hammond | March 7, 2023 |
| Long acting injectables for psychiatric patients | Mackenzie Walker | March 9, 2023 |
| TBD | Clint | March 13, 2023 |
| Biomarkers for the detection and targeted management of rejection after transplantation | Brianna North | March 14, 2023 |
| Management of Stenotrophomonas maltophilia infections – should TMP/SMX be considered first line | Jackie Espinoza-Ramirez | March 15, 2023 |
| TBD | Nahla Hachmi | March 22, 2023 |
| TBD | Rianna Rea | April 3, 2023 |
| Dual therapy for MRSA Bacteremia/endocarditis – is two better than one? | Reginald Leandre | April 5, 2023 |
| TBD | Carolyn Cooley | April 12, 2023 |
| TBD | Alvin Tomika | April 19, 2023 |
| TBD | Marquis Smith | April 26, 2023 |
| Serotonin Syndrome Risks, Diagnosis and Management | Nhi Tran | May 3, 2023 |
| Phenobarbital in AWS, Updating our approach to treatment | Christian Cayabyab | June 14, 2023 |
Disclosure Statement
The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
- Bibidh Subedi, Pharm.D., BCCCP – AdventHealth Orlando, Critical Care Pharmacy Specialist | Medical ICU
- Myla Nguyen
- Amber Johnson
- Keaton Kaplan
- Jessica Behnam
- Rosie Nagy
- Patrick Funderburk
- Alexis Ertle
- Ariana Terravecchia
- Yeji Lee
- Emma Ballantyne
- Taylor Vandenberg
- Maha Fansa
- Gabriella Perez
- Olivia Funk
- Michelle Dillon
- Jennifer Wilson
- Emily Bennett
- Alexandra Cunha
- Lindsey Selph
- Brittany Allison
- Alexandra Cruz Pabon
- Rebecca Falter
- Maitri Patel
- Caitlyn Lawrence
- Cheng Ieng Wong
- Nicholas Hammond
- Mackenzie Walker
- Clint
- Brianna North
- Jackie Espinoza-Ramirez
- Nahla Hachmi
- Rianna Rea
- Carolyn Cooley
- Alvin Tomika
- Marquis Smith
- Christian Cayabyab
- Jose Lugo-Martinez
Additional Resources
Please review the resources below before registering for the course.
The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.